DHX9 was identified as one of the antiviral RNA helicases for which targeted knockdown enhanced MYXV replication in multiple cancer cell types that are normally permissive, semipermissive, and nonpermissive to MYXV replication. The gene discussed is DHX9; the disease is cancer.